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Pharmacists’ role in harm reduction: a
survey assessment of Kentucky community
pharmacists’ willingness to participate in
syringe/needle exchange
Amie Goodin1* , Amanda Fallin-Bennett2, Traci Green3 and Patricia R. Freeman4
Abstract
Background: Pharmacists’ role in harm reduction is expanding in many states, yet there are limited data on
pharmacists’ willingness to participate in harm reduction activities. This study assessed community pharmacists’
willingness to participate in one harm reduction initiative: syringe/needle exchange.
Methods: In 2015, all Kentucky pharmacists with active licenses were emailed a survey that examined attitudes
towards participation in syringe/needle exchange. Response frequencies were calculated for community pharmacist
respondents. Ordinal logistic regression estimated the impact of community pharmacist characteristics and attitudes
on willingness to provide clean needles/syringes to people who inject drugs and to dispose of used syringes/
needles, where both dependent variables were defined as Likert-type questions on a scale of 1 (not at all willing) to
6 (very willing).
Results: Of 4699 practicing Kentucky pharmacists, 1282 pharmacists responded (response rate = 27.3%); the
majority (n = 827) were community pharmacists. Community pharmacists were divided on willingness to provide
clean needles/syringes, with 39.1% not willing (score 1 or 2 of 6) and 30% very willing (score 5 or 6 of 6). Few were
willing to dispose of used needles/syringes, with only 18.7% willing. Community pharmacists who agreed that
pharmacists could have significant public health impact by providing access to clean needles expressed 3.56 times
more willingness to provide clean needles (95% CI 3.06–4.15), and 2.04 times more willingness to dispose of used
needles (95% CI 1.77–2.35). Chain/supermarket pharmacists (n = 485, 58.6% of community pharmacies) were 39%
less likely to express willingness to dispose of used needles (95% CI 0.43–0.87) when compared with independent
community pharmacists (n = 342, 41.4% of community pharmacies). Independent pharmacists reported different
barriers (workflow) than their chain/supermarket pharmacist colleagues (concerns of clientele).
Conclusions: Kentucky community pharmacists were more willing to provide clean needles than to dispose of
used needles. Strategies to mitigate barriers to participation in syringe/needle exchange are warranted.
Keywords: Needle exchange, Syringe exchange, Harm reduction, Community pharmacy practice, Injection drug
use, Prevention
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Background
Syringe and needle exchange programs (NEPs) are a
well-established intervention to reduce the transmission
of HIV among people who inject drugs (PWID) [1]. Fur-
ther, NEPs are a safe space for clients to form trusted re-
lationships with outreach workers or healthcare
providers [2, 3]. NEPs can also serve as a mechanism for
PWID to access a range of other health prevention ser-
vices such as hepatitis and tuberculosis screening, adult
vaccinations, [4] wound care, [5], and overdose response
training [5, 6].
Harm reduction activities, including NEPs for PWID,
have been led by public health communities for decades
in the USA. The pharmacists’ role in harm reduction is
being expanded in several states as part of the effort to
combat the spread of infectious disease and increases in
overdose mortality [7]. Though NEPs have been shown
to be both effective [8] and cost-effective [9] interven-
tions for disease prevention in previous studies, they re-
main politically controversial [10] in the general
populace, manifesting as inconsistencies in federal and
state funding for NEP services [11].
A 2017 meta-analysis of 14 evaluations of pharmacy-
based NEPs concluded that pharmacy-based programs
are effective interventions in reducing risk behaviors
among PWID, yet in the USA, few such programs exist
[12]. As an alternative to authorizing true NEPs, many
states have expanded access to clean needles and syrin-
ges by authorizing the sale of syringes and needles with-
out a prescription and have provided syringe-related
exemptions in state drug paraphernalia laws. As of 2016,
only five states prohibited the non-prescription sale of
syringes and needles [13]. However, Kentucky, similar to
many other states, requires the pharmacist to record
names and addresses of individuals purchasing syringes,
as well as the syringes’ intended use. This requirement
may undermine patient trust and places the pharmacist
in conflict with state drug paraphernalia laws if the
pharmacist perceives the syringes are to be used to ad-
minister illicit drugs.
The Centers for Disease Control and Prevention re-
ports that Kentucky, Tennessee, and West Virginia have
experienced the greatest surge in incidence of acute
hepatitis B infections of all states, with an increase of
114% in new hepatitis B cases from 2009 to 2013, while
incidence in other states remained stable during this
time period [14]. Kentucky and surrounding states have
also experienced a 364% increase in incidence of hepa-
titis C infections between 2006 and 2012 compared with
relatively stable incidence of hepatitis C in other states
during this time period [15]. The increase in hepatitis B
and C infections, along with an increase in observed in-
cidence of HIV transmission in neighboring Indiana dur-
ing this time period, [16] has been driven by injection
drug use of heroin and prescription opioids. These ex-
plosive increases in the transmission of blood-borne vi-
ruses recently observed in Kentucky and surrounding
states have fueled legislative efforts for harm reduction.
Kentucky passed legislation in March 2015 granting mu-
nicipalities the authority to implement NEPs and provid-
ing exemptions for these programs from Kentucky’s
drug paraphernalia laws [17]. Non-medical injection
users of prescription opioids in other states often access
needles and syringes from pharmacies, [18–20] which
presents an opportunity for harm reduction interven-
tions in community pharmacy settings if they, too, could
be granted a similar drug paraphernalia law exemption.
However, there is little information available in the lit-
erature about pharmacists’ changing perceptions of these
programs after the recent increase in overdose mortality
and rise in injection-driven infections, so the potential
for widespread implementation in Kentucky remains un-
clear. The objective of this study was to assess commu-
nity pharmacists’ willingness to participate in a NEP and
to gauge attitudes and perceptions of community phar-
macists’ role in harm reduction efforts related to over-
dose and their role in public health.
Methods
A survey instrument was developed to assess pharmacist
overall perception and attitudes about the pharmacists’
role in harm reduction activities with regard to injection
drug use and opioid overdose, as well as willingness to
participate in select elements of NEPs, namely, providing
clean needles and syringes to PWID and disposing of used
syringes and needles in their pharmacy. A team of prac-
ticing pharmacists and pharmaceutical policy researchers
developed the survey questions and adapted question sets
from previous surveys [21, 22] and then partnered with
Kentucky Board of Pharmacy (BOP) for assistance in sur-
vey distribution and promotion to pharmacists. The sur-
vey instrument is available as Supplementary Material (see
Additional file 1—Survey instrument).
The BOP distributed an email containing a cover letter
with an explanation of the study and a link to the elec-
tronic survey to all pharmacists licensed to practice in
Kentucky on June 23, 2015. Respondents were screened
for eligibility prior to the beginning of the survey by
affirming active Kentucky pharmacist licensure. Those
who did not affirm licensure were exited from the sur-
vey. Survey data were collected in the web-based appli-
cation Research Electronic Data Capture (REDCap) [23],
and no identifying information or linkages to either re-
spondent email addresses nor IP addresses were re-
corded with survey responses.
A reminder email was delivered to all pharmacists
1 week following the initial survey invitation, and a final
reminder and call to participation was distributed via
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email 2 weeks following initial contact. Two weeks after the
final email reminder, the survey link was deactivated and
data collection was stopped. The University of Kentucky In-
stitutional Review Board approved the survey protocol.
Variables and statistical analysis
Response frequencies were recorded for each question,
and descriptive statistics were calculated for pharmacist
characteristics and for attitudes about the pharmacists’
role in harm reduction (Table 1). Respondents had to
answer at least one question on the survey beyond the
screening question to be included in analysis. Non-
community pharmacists (e.g., hospitalists, those prac-
ticing in long-term care settings) were excluded from
this analysis. Non-community pharmacists were ex-
cluded from the analysis to ensure that pharmacist opin-
ion was assessed in respondents most likely to practice
in patient-facing settings. Pharmacists practicing in in-
patient facilities or long-term care environments have
limited access to patient populations in need of needle
exchange services.
Two dependent variables were selected for multivari-
ate analyses: community pharmacist willingness to pro-
vide clean needles/syringes and community pharmacist
willingness to dispose of used needles/syringes. Both of
the dependent variables were derived from Likert-type
question items (e.g., “How willing are you to provide
clean needles and syringes to injection drug users?” Re-
sponse options included a scale from 1, which represents
“not at all willing,” through 6, which represented “very
willing.” The rank order nature of the dependent vari-
ables indicated use of ordinal regression, which was
employed to estimate the impact of community pharma-
cist characteristics (e.g., pharmacist age, degree type,
gender, years in practice, community pharmacy practice
setting, whether they currently sell nonprescription nee-
dles/syringes, urban or rural practice setting, county of
practice) and attitudes towards harm reduction on each
of the dependent variables. Ordinality was comprised of
the six response categories as they appeared on the sur-
vey instrument, where the reference category for both of
the dependent variables is “1” (not at all willing). Alter-
native specifications of the model were created that lim-
ited analysis to only those community pharmacists who
currently sell needles and syringes in their practice and
limiting to only those who do not sell needles and syrin-
ges in their practice (see Additional file 2: Table S1). To
understand how practice setting may influence syringe
provision practices and willingness and attitudes toward
harm reduction, several additional analyses considered
differences by chain and supermarket community phar-
macy setting.
Predictor and independent variables in the multivariate
model were selected based on a backward elimination
strategy from the model, where all demographic ques-
tions were included in the first model construction and
variables were eliminated due to either multicollinearity
(pharmacist age and pharmacist years in practice, with
age eliminated), or poor model fit (pharmacist county of
practice was re-coded as the better fitting “urban” or
“rural” county). Pharmacist county of practice was trans-
formed to “urban” or “rural” practice setting using the
US Department of Agriculture Rural-Urban Continuum
Codes, which classifies all counties based on population
thresholds [24]. Model variables were tested for multi-
collinearity via the construction of a correlation matrix,
resulting in elimination of the pharmacist age variable
from the final model.
Two assessment items of pharmacist attitudes towards
harm reduction were included on the survey instrument:
“Pharmacists could have significant public health impact
by providing access to syringes/needles for IV drug
users,” and “Access to clean syringes/needles is import-
ant to prevent blood-borne infections such as HIV and
hepatitis in IV drug users.” These items were con-
structed as Likert-type items, where respondents were
asked to select a level of agreement with each statement
on a scale of 1 to 6 (with 1 representing “strongly
Table 1 Kentucky community pharmacists’ characteristics (n =
827)
n (%)
Terminal degree
BSPharm 371 (44.9)
PharmD 445 (53.8)
Other degree (PhD, others) 9 (1.1)
No response 2 (0.2)
Years in practice
0 to 5 years 203 (24.6)
6 to 10 years 124 (15)
11 to 20 years 157 (19)
> 20 years 341 (41)
No response 2 (0.2)
Pharmacist gender
Female 417 (50.4)
Male 393 (47.5)
Prefer not to answer 17 (2.1)
Community pharmacy practice setting
Chain or supermarket pharmacy 485 (58.6)
Independent pharmacy 342 (41.4)
Urban or rural practice setting
Urban county 407 (49.2)
Rural county 395 (47.8)
County not provided 25 (3.0)
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disagree” and 6 representing “strongly agree”). Responses
to these attitude assessments were also included as pre-
dictor variables in the multivariate models, but re-
sponses of “Don’t know” for these questions were
omitted from analysis.
Needle and syringe sales practices were summarized
from survey questions about frequency of sales and re-
fusal to sell nonprescription needles and syringes (i.e.,
“Do you sell syringes and needles without a prescription
at your pharmacy?” [Yes or No]; “In the last 30 days, to
how many individuals have you sold syringes and nee-
dles?”; “In the past 30 days, how many times have you
denied requests for the purchase of syringes or nee-
dles?”). Responses about mean sales and mean sale re-
fusals from chain and supermarket community
pharmacists were compared against responses from in-
dependent community pharmacists using two-tailed Stu-
dent’s t testing. Additionally, bivariate testing using
Pearson chi-square analysis of willingness to sell nonpre-
scription needles/syringes, willingness to provide clean
needles/syringes, and willingness to dispose of used nee-
dles/syringes were conducted between independent
community pharmacists and chain/supermarket commu-
nity pharmacists who currently sell needles and syringes
in their practice. This analysis was repeated for only
those community pharmacists who currently do not sell
needles and syringes in their practice.
Pharmacists provided free-text responses to the ques-
tion, “What are the barriers to selling syringes or needles
without a prescription at your pharmacy?”. Community
pharmacist-reported barriers to selling syringes and nee-
dles were analyzed for common themes, and the fre-
quency of occurrence for each barrier theme was
counted for all community pharmacists, and then by
practice setting. Responses of “Don’t Know,” “Unsure,”
“NA,” and “None,” were not included in the analysis.
Differences in the frequency of each barrier theme re-
ported between independent pharmacists and chain/
supermarket pharmacists were compared statistically
using Pearson chi-square analysis. A priori significance
was set at 0.05, and all statistical analyses were con-
ducted in Stata v13.0 [25].
Results
An email survey invitation was successfully delivered to
4699 Kentucky pharmacists and 1282 completed the survey
(response rate of 27.28%). Only community pharmacists
were included in analysis (n = 827). Nearly 60% of respon-
dents practiced in chain or supermarket community phar-
macies, and more than half of respondents had been in
practice for over 10 years. Distribution of pharmacists be-
tween urban and rural practice settings was evenly split.
Pharmacists were divided on willingness to provide
clean needles and syringes, with 39.1% not willing (score 1
or 2 of 6) and 30% willing (score 5 or 6 of 6). Few pharma-
cists expressed willingness to dispose of used needles and
syringes, with 62.6% not willing (score 1 or 2 of 6) and
only 18.7% willing (score 5 or 6 of 6). Figure 1 shows re-
sponses for willingness to participate in NEP activities
while Fig. 2 provides a distribution of responses for phar-
macists’ attitudes towards harm reduction strategies.
Community pharmacists were divided about the state-
ment, “Pharmacists could have a significant public
health impact by providing access to syringes and nee-
dles for injection drug users,” with about a third of re-
spondents unable to agree or disagree (Fig. 2). More
than two thirds of community pharmacists strongly
agree that “access to clean syringes and needles is im-
portant to prevent blood-borne infections such as HIV
and hepatitis” in PWIDs (67.3%, 5 or 6 of 6) and with
only 10.2% of community pharmacists strongly disagree-
ing with that statement (score 1 or 2 of 6).
Fig. 1 Community pharmacists’ willingness to participate in needle exchange (n= 705). Wilingness scores were collapsed for clarity (1 and 2 = not willing,
3 and 4 = in the middle, 5 and 6 = willing). Responses of “Don’t Know” are not included on the figure
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Table 2 provides results from the multivariate analyses.
Community pharmacists who expressed agreement with
the statement that pharmacists could have significant
public health impact by providing access to clean syrin-
ges/needles for PWID were more likely to express will-
ingness to provide clean needles and syringes (OR 3.56;
95% CI 3.06–4.15) and were also more likely to express
willingness to dispose of used needles and syringes (OR
2.04; 95% CI 1.77–2.35).
Community pharmacist agreement with the statement
that clean syringes/needles are important for blood-
borne infection prevention was not a significant pre-
dictor of pharmacist willingness to provide clean nee-
dles/syringes nor to dispose of used needles/syringes.
Community pharmacists in chain or supermarket phar-
macy practice settings were 39% less likely to express
willingness to dispose of used needles/syringes (95% CI
0.43–0.87) when compared with community pharmacists
in independent practice settings. Female pharmacists
were 28% less likely to express willingness to dispose of
used needles/syringes than male pharmacists (95% CI
0.52–0.99). No other pharmacist characteristics mea-
sured in this survey were associated with willingness to
provide clean needles/syringes or willingness to dispose
of used needles/syringes.
Additional file 2: Table S1 provides results for two alter-
native specifications of the multivariate models, where
only those community pharmacists who currently sell
needles and syringes were included in alternative specifi-
cation A, and those who do not sell needles and syringes
were included in alternative specification B. Results were
similar in the alternative specifications to the results pre-
sented in Table 2, with the only significant covariate for
both willingness to provide clean needles and willingness
to dispose of used needles found among those who agreed
that pharmacists could have a significant public health
impact by providing access to syringes/needles for IV drug
users and who currently sell needles/syringes (willingness
to provide clean needles aOR 3.82, 95% CI 3.11–4.69; will-
ingness to dispose of used needles aOR 2.25, 95% CI
1.84–2.75). Pharmacist agreement with having a signifi-
cant public health impact remained the only significant
covariate for willingness to provide clean needles among
pharmacists who do not currently sell needles/syringes
(aOR 3.34; 95% CI 2.64–4.24). In the model that incorpo-
rated those who do not currently sell syringes/needles,
only female gender and practicing in a chain/supermarket
pharmacy were significant factors in willingness to dispose
of used needles (female aOR 0.47, 95% CI 0.27–0.84;
chain/supermarket aOR 0.39, 95% CI 0.21–0.73)
Table 3 summarizes needle and syringe sales practices
among community pharmacists, with chain and super-
market pharmacists compared against independent com-
munity pharmacists. More than a third of community
pharmacists reported that they currently do not sell sy-
ringes/needles without a prescription at their pharmacies
(36.7% do not sell, 63.3% will sell), with significantly
fewer independent community pharmacists selling nee-
dles/syringes without a prescription than chain/super-
market community pharmacists (51.9% independent
pharmacists sell; 71.5% chain/supermarket community
pharmacists sell; p < 0.01). Chain/supermarket com-
munity pharmacists, on average, also report selling
more syringes and needles than independent pharmacists
(p = 0.01); however, chain/supermarket community phar-
macists also report denying requests for syringes/needles
more often than their independent community pharmacist
counterparts (p < 0.01).
Independent pharmacists were, on average, more willing
to provide clean needles/syringes (p = 0.04) as well as
more likely to dispose of used needles/syringes (p < 0.01)
when compared with their chain/supermarket pharmacist
Fig. 2 Community pharmacists’ attitudes towards harm reduction (n = 716). Agreement scores were collapsed for clarity (1 and 2 = strongly
disagree, 3 and 4 = in the middle, 5 and 6 = strongly agree). Responses of “Don’t Know” are not included on the figure
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counterparts. Among all community pharmacists, a major-
ity (62.6%) expressed unwillingness to dispose of used sy-
ringes and needles (score 1 or 2 of 6) but fewer (39.1%)
were unwilling to provide clean needles and syringes (score
1 or 2 of 6). Among community pharmacists who do not
currently sell needles, independent pharmacists were more
likely to report willingness to dispose of used needles and
syringes than chain/supermarket pharmacists (p < 0.01), but
no statistically significant difference was observed for will-
ingness to provide clean needles and syringes between inde-
pendent and chain/supermarket pharmacists who currently
do not sell needles/syringes (p = 0.08).
Table 4 summarizes the most frequently occurring re-
sponses to the open response question, “What are the
barriers to selling syringes or needles without a prescrip-
tion at your pharmacy?” A total of n = 172 community
pharmacists (20.8% of community pharmacist respon-
dents) reported at least one barrier to selling syringes or
needles, and n = 655 community pharmacists did not ar-
ticulate a barrier. Overall, most respondents who re-
ported facing a barrier to selling syringes or needles in
their pharmacies indicated that ethical concerns about
supplying materials for abuse or illegitimate use was a
significant barrier (n = 71, or 41.3% of all community
pharmacist respondents), followed by concerns about
the clientele who would patronize the pharmacy (n = 44,
or 25.6% of all community pharmacist respondents).
Chain/supermarket pharmacists reported barriers re-
lated to clientele concerns significantly more frequently
than independent pharmacists (p < 0.01), as well as more
frequent barriers related to concern about finding or
having to handle used needles when compared with in-
dependent pharmacists (p = 0.01). Independent pharma-
cists reported barriers related to problems with record
keeping practices significantly more frequently than
chain/supermarket pharmacists (p = 0.02). This suggests
that there are different barriers to selling needles and sy-
ringes perceived by independent versus chain/supermar-
ket pharmacists.
Discussion
Kentucky community pharmacists in any practice setting
expressed more willingness to provide clean needles and
syringes than to dispose of used needles and syringes.
This mirrors results from a recent evaluation of patient
experiences with pharmacy-based NEPs in China which
found that disposal of used needles was the most prob-
lematic element [26]. Only 63.3% of surveyed commu-
nity pharmacists in Kentucky currently permit sales of
needles/syringes without a prescription despite state law
that authorizes non-prescription sales. The findings of
this study in regard to the attitudes related to the
provision and disposal of needles and syringes suggest
that efforts to promote NEPs in Kentucky may more
Table 2 Community pharmacists’ willingness to participate in
needle exchange activities, ordinal logistic regression analysis
results
Willingness to
provide clean
needles and
syringes2
(n = 628)
Willingness
to dispose of
used needles
and syringes2
(n = 632)
Adjusted
odds
ratio
95%
CI
Adjusted
odds
ratio
95%
CI
Terminal degree
BSPharm Ref. Ref.
PharmD 1.00 0.60–
1.67
1.40 0.82–
2.40
Years in practice
0 to 5 years Ref. Ref.
6 to 10 years 0.76 0.46–
1.25
0.77 0.46–
1.29
11 to 20 years 1.30 0.82–
2.08
1.48 0.91–
2.42
> 20 years 0.93 0.50–
1.70
1.51 0.80–
2.82
Pharmacist gender
Female 0.74 0.54–
1.01
0.72* 0.52–
0.99
Male Ref. Ref.
Community pharmacy practice setting
Chain or supermarket pharmacy 0.92 0.65–
1.30
0.61* 0.43–
0.87
Independent pharmacy Ref. Ref.
Urban or rural practice setting
Urban county 1.04 0.75–
1.44
0.96 0.69–
1.33
Rural county Ref. Ref.
Sells needles/syringes without a prescription
Yes, sells needles/syringes 1.19 0.85–
1.65
0.92 0.66–
1.29
No, does not sell needles/
syringes
Ref. Ref.
Pharmacist attitudes1
Pharmacists could have
significant public health impact by
providing access to syringes/
needles for IV drug users
3.56* 3.06–
4.15
2.04* 1.77–
2.35
Access to clean syringes/needles
is important to prevent blood-
borne infections such as HIV and
hepatitis in IV drug users
1.04 0.91–
1.20
0.91 0.78–
1.06
1Respondents could select a response on a scale of 1 (strongly disagree) to 6
(strongly agree) for each attitude question. Responses of “Don’t Know” were
not included in regression analysis
2The reference group for the dependent variable in both willingness models is
a response of 1 (Not at all willing)
*Indicates statistical significance
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successfully target independent community pharmacists
based on expressed reluctance from chain and super-
market community pharmacists; however, community
pharmacists in either setting are better positioned to
provide convenient access to these types of services
when compared to pharmacists in other practice settings
(e.g., hospitalists, long-term care). It should be noted,
however, that there is room for improvement among
pharmacy-based protocols to address safety precau-
tions as well as attitudes towards syringe provision
and disposal among all community pharmacist groups.
Interestingly, few differences were found among opin-
ions between pharmacists practicing in rural and
urban settings.
NEPs offered through fixed-location pharmacies at-
tract a different demographic mix of patients when
compared to mobile exchange service sites operating
in the same area, [27] which suggests that different
venues will attract different subsets of those who
need access to NEPs. Promising pilot programs have
also demonstrated that NEPs offered through pharma-
cies have been able to link clients to medical and social
services more successfully than traditional exchange pro-
gram sites [28]. Considering that community pharmacists
reported significant barriers to selling nonprescription
needles and syringes based on their concerns about ethics
and clientele, the findings from this study suggest that
substantial pharmacist education and outreach are
needed. To address issues with workflow, the removal of
requirements for recording syringe and needle purchases
as well as standardization of protocol and process for syr-
inge/needle storage, disposal, billing, physical location for
placement, and co-messaging for syringe/needle disposal
containment are warranted.
Table 3 Community pharmacists’ self-reported needle and syringe sales practices, independent pharmacists vs. chain/supermarket
pharmacists
Needle/syringe sales practice All community
pharmacists
Independent
pharmacists
Chain/supermarket
pharmacists
Independent vs. chain/
supermarket1
N (%) N (%) N (%) P value
Do you sell needles and syringes without a prescription in your pharmacy?
Yes 445 (63.3) 152 (51.9) 293 (71.5) < 0.01*
No 258 (36.7) 141 (48.1) 117 (28.5)
Among all community pharmacists: “How willing are you to provide clean needles and syringes?”
Willing (5 or 6) 210 (30.0) 100 (33.8) 110 (27.2)
In the middle (3 or 4) 217 (31.0) 85 (28.7) 132 (32.6) 0.04*
Not at all willing (1 or 2) 274 (39.1) 111 (37.5) 163 (40.2)
Among all community pharmacists: “How willing are you to dispose of used needles and syringes?”
Willing (5 or 6) 132 (18.7) 70 (23.7) 62 (15.2)
In the middle (3 or 4) 132 (18.7) 60 (20.3) 72 (17.6) < 0.01*
Not at all willing (1 or 2) 441 (62.6) 166 (56.1) 275 (67.2)
Only those who do not sell needles: “How willing are you to provide clean needles and syringes?”
Willing (5 or 6) 50 (20.41) 34 (25.19) 16 (14.55)
In the middle (3 or 4) 74 (30.20) 40 (29.63) 34 (30.91) 0.08
Not at all willing (1 or 2) 121 (49.39) 61 (45.19) 60 (54.55)
Only those who do not sell needles: “How willing are you to dispose of used needles and syringes?”
Willing (5 or 6) 41 (16.33) 29 (21.01) 12 (10.62)
In the middle (3 or 4) 48 (19.12) 32 (23.19) 16 (14.16) < 0.01*
Not at all willing (1 or 2) 162 (64.54) 77 (55.80) 85 (75.22)
Mean (SD) Mean (SD) Mean (SD) P value
In the last 30 days, to how many individuals have you sold
syringes and needles?
10.29 (30.4) 4.79 (7.4) 13.20 (36.9) 0.01*
In the past 30 days, how many times have you DENIED requests
for purchase of syringes or needles?
2.51 (4.9) 1.36 (4.5) 3.12 (5.0) < 0.01*
1Differences in response frequencies for independent vs. chain/supermarket pharmacist responses were compared via chi-square analysis for the question, “Do
you sell needles and syringes without a prescription in your pharmacy?” Willingness to provide and dispose of needles and syringes between independent and
chain/supermarket pharmacists were also compared via chi-square analysis. All other comparisons between independent and chain/supermarket pharmacists were
conducted via means testing (two-tailed t tests)
*Indicates statistical significance
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The American Pharmacists Association (APhA) recently
published a call for community pharmacists to engage in
harm reduction and public health-driven activities to ad-
dress the opioid epidemic, with specific mention of super-
vised injection sites and the selling of nonprescription
needles and syringes [29]. APhA and other professional or-
ganizations have the opportunity to engage with community
pharmacists by expanding access to continuing education
interventions and promoting the adoption of clear workflow
guidelines and protocols by chain and supermarket commu-
nity pharmacies, whose pharmacists demonstrated more re-
luctance to participate in NEP services in this survey when
compared with independent community pharmacists. Add-
itionally, universities and schools that train pharmacists
should update and modify public health curriculum by in-
cluding educational modules on harm reduction opportun-
ities and responsibilities for pharmacists in community
practice settings. Kentucky in particular may benefit from a
harm reduction public health tool like NEPs when consider-
ing that surveillance systems from the Centers for Disease
Control and Prevention report that the highest rates of acute
hepatitis B and C infections in the USA were found in Ken-
tucky from 2010 through 2013 [30].
This study has several limitations. First, it is possible
that nonresponse bias from the pharmacists who did not
choose to participate influenced findings. The response
rate is low compared to traditional mail surveys, though
this was found to be within the typical range observed in
contemporary studies employing electronically delivered
surveys [31]. Also, it is possible (and perhaps likely) that
the attitudes and opinions of Kentucky pharmacists are
not generalizable to or representative of pharmacists in
other states or countries. Additionally, Kentucky may
have a greater proportion of independent pharmacies
than is typically found in other states, which may have
contributed to the ability to detect differences by prac-
tice setting and conclusions related to harm reduction
efforts with independent pharmacies and may limit
generalizability of our findings to locations with different
pharmacy setting characteristics.
Conclusions
Kentucky community pharmacists report uncertainty about
their role in harm reduction and NEPs in particular; how-
ever, they mostly agree that they do have a role to play in
public health prevention efforts. Community pharmacists
report significant barriers to selling/providing nonprescrip-
tion needles and syringes and report even larger barriers for
disposing of used needles and syringes in their pharmacies.
Pharmacists practicing in independently owned pharmacies
in Kentucky appear to be more receptive to selling than
pharmacists working in chain or supermarket pharmacies,
though pharmacists in chain practice settings currently re-
port selling needles and syringes at a greater volume than
their independent pharmacist counterparts.
Additional file
Additional file 1: Survey Instrument. (PDF 73 kb)
Additional file 2: Table S1. Willingness to participate in needle
exchange activities among community pharmacists who do or do not
currently sell needles and syringes, ordinal logistic regression analysis
results. (DOCX 15 kb)
Abbreviations
BOP: Board of pharmacy; CI: Confidence interval; HIV: Human
immunodeficiency virus; IV: Intravenous; NEP: Needle exchange program;
OR: Odds ratio; PWID: People who inject drugs; REDCap: Research electronic
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Table 4 Frequently reported barriers to selling syringes/needles without a prescription, as reported by Kentucky community
pharmacists
Theme of reported barrier All community
pharmacists (n = 172)1
Independent
pharmacists (n = 85)
Chain/supermarket
pharmacists (n = 87)
Independent vs. chain/
supermarket
n n (%) n (%) p value
Concern about clientele in the pharmacy 44 11 (25.0) 33 (75.0) < 0.01*
Ethical concerns about supplying materials for
abuse or illegitimate use
71 40 (56.3) 31 (43.7) 0.13
Conflict with city ordinance or company
policy
25 13 (52.0) 12 (48.0) 0.78
Other legal concerns 7 3 (42.9) 4 (57.1) 0.72
Problems with record-keeping 22 16 (72.7) 6 (27.3) 0.02*
Time 6 3 (50.0) 3 (50.0) 0.98
Reputation with colleagues or community 5 2 (40.0) 3 (60.0) 0.67
Concern of finding or handling used needles 6 0 (0.00) 6 (100.00) 0.01*
Supply problems 3 1 (33.3) 2 (66.7) 0.57
1Respondent may have written more than one comment for this question, so totals do not sum to 100%
*Indicates statistical significance
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